Izumi K - Search Results

1

Brunsting-Perry type pemphigoid with IgG antibody against full-length BP180 mimicking squamous cell carcinoma.

Kakurai M, Kubota N, Ishii Y, Izumi K, Nomura T. Kakurai M, et al. Among authors: izumi k. J Dermatol. 2023 Aug;50(8):e234-e235. doi: 10.1111/1346-8138.16758. Epub 2023 Feb 27. J Dermatol. 2023. PMID: 36852485 No abstract available.

2

A case of bullous pemphigoid developing under treatment with benralizumab for bronchial asthma.

Tanaka A, Fujimura Y, Fuke S, Izumi K, Ujiie H. Tanaka A, et al. Among authors: izumi k. J Dermatol. 2023 Sep;50(9):1199-1202. doi: 10.1111/1346-8138.16811. Epub 2023 Apr 30. J Dermatol. 2023. PMID: 37122191

3

Pemphigoid Nodularis Induced by Long-Term Use of Dipeptidyl Peptidase-4 Inhibitors.

Norikawa N, Irie K, Ishikawa M, Hiraiwa T, Izumi K, Yamamoto T. Norikawa N, et al. Among authors: izumi k. Indian J Dermatol. 2023 Jan-Feb;68(1):104-105. doi: 10.4103/ijd.ijd_632_22. Indian J Dermatol. 2023. PMID: 37151239 Free PMC article. No abstract available.

4

Association of Genetic Variants of HLA-DQA1 with Bullous Pemphigoid Induced by Dipeptidyl Peptidase-4 Inhibitors.

Ozeki T, Muramatsu K, Yoshimoto N, Ujiie I, Izumi K, Iwata H, Mushiroda T, Ujiie H. Ozeki T, et al. Among authors: izumi k. J Invest Dermatol. 2023 Nov;143(11):2219-2225.e5. doi: 10.1016/j.jid.2023.04.017. Epub 2023 May 6. J Invest Dermatol. 2023. PMID: 37156394 Free article.

5

Bullous pemphigoid with autoantibodies against full-length BP180 protein after COVID-19 infection.

Oya K, Kakurai M, Izumi K, Ishii N, Nomura T. Oya K, et al. Among authors: izumi k. J Eur Acad Dermatol Venereol. 2023 Nov;37(11):e1266-e1267. doi: 10.1111/jdv.19373. Epub 2023 Jul 26. J Eur Acad Dermatol Venereol. 2023. PMID: 37471499 No abstract available.

6

A case of rapidly progressive hair loss due to azathioprine, and the prevalence of NUDT15 variants among Japanese patients with autoimmune blistering diseases: A single-center retrospective observational study.

Katayama S, Izumi K, Ujiie I, Ujiie H. Katayama S, et al. Among authors: izumi k. J Dermatol. 2024 Oct 26. doi: 10.1111/1346-8138.17515. Online ahead of print. J Dermatol. 2024. PMID: 39460498

7

Detection of a natural antibody targeting the shed ectodomain of BP180 in mice.

Mai Y, Izumi K, Mai S, Nishie W, Ujiie H. Mai Y, et al. Among authors: izumi k. J Dermatol Sci. 2023 Oct;112(1):15-22. doi: 10.1016/j.jdermsci.2023.07.009. Epub 2023 Aug 1. J Dermatol Sci. 2023. PMID: 37550175

8

Transcriptomic response of peripheral blood mononuclear cells to dupilumab in a 65-year-old patient with bullous pemphigoid.

Li ML, Hong YK, Lin YC, Natsuga K, Ujiie H, Izumi K, Iwata H, Hsu CK. Li ML, et al. Among authors: izumi k. Clin Exp Dermatol. 2023 Dec 19;49(1):73-74. doi: 10.1093/ced/llad293. Clin Exp Dermatol. 2023. PMID: 37650504 No abstract available.

9

Type XVII Collagen-Specific CD4⁺ T Cells Induce Bullous Pemphigoid by Producing IL-5.

Yoshimoto N, Muramastsu K, Ito T, Zheng M, Izumi K, Natsuga K, Iwata H, Hasegawa Y, Ujiie H. Yoshimoto N, et al. Among authors: izumi k. J Invest Dermatol. 2024 Sep 24:S0022-202X(24)02104-3. doi: 10.1016/j.jid.2024.08.026. Online ahead of print. J Invest Dermatol. 2024. PMID: 39326663 Free article.

10

Clinical characteristics and outcomes of dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid patients: A retrospective study.

Ujiie I, Katayama S, Mai Y, Mai S, Yoshimoto N, Muramatsu K, Iwata H, Izumi K, Ujiie H. Ujiie I, et al. Among authors: izumi k. J Am Acad Dermatol. 2024 Oct 21:S0190-9622(24)03033-0. doi: 10.1016/j.jaad.2024.09.067. Online ahead of print. J Am Acad Dermatol. 2024. PMID: 39442884 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,534 results

Search Page

Filters